Study: qSOFA Predicts Mortality in ED Patients with Suspected Infection
See Also: Study: SOFA Score Helps Predict ICU Mortality
These findings provide support for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria in the ED setting. Due to poor specificity and sensitivity, the SIRS and the previous definitions of "sepsis" and "severe sepsis" were replaced with the new state of sepsis defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection.
Sepsis is now identified by an increase of at least 2 points in the SOFA score in patients with a suspicion of infection. The qSOFA score, a surrogate for SOFA in settings in which all components of SOFA are not routinely measured, was introduced to screen for patients likely to have sepsis.
The new study assessed the external validity of the recently developed Sepsis-3 criteria among patients presenting to the ED and compared these criteria to prior guidelines that use the SIRS score and serum lactate levels. The international prospective cohort study was conducted in France, Spain, Belgium, and Switzerland between May and June 2016. In the 30 participating emergency departments, for a four-week period, consecutive patients who visited the EDs with suspected infection were included. All variables from previous and new definitions of sepsis were collected. Patients were followed up until hospital discharge or death.
Of 1,088 patients screened, 879 were included in the analysis. Median age was 67 years (interquartile range, 47-81 years), 414 (47 percent) were women, and 379 (43 percent) had respiratory tract infection. Overall, in-hospital mortality was 8 percent. For patients with qSOFA scores less than 2, the mortality rate was 3 percent (95% CI, 2%-5%) vs. 24 percent (95% CI, 18%-30%) for patients with a qSOFA score of 2 or higher (absolute difference, 21%; 95% CI, 15%-26%).
"The very low mortality rate of patients with qSOFA score less than 2 is a strong argument to replace SIRS without the risk of missing critically ill patients," the study says. "Moreover, there was no difference in the rate of the false negative of SIRS and qSOFA for the prediction of death or ICU stay of more than 72 hours (7%; 95% CI, 4%-10% and 9%; 95% CI, 7%-11%).
Although qSOFA was not meant to replace SIRS in the definition of sepsis but rather help clinicians for early detection of sepsis, the authors note that these results suggest that ED patients with infection and a qSOFA score of 2 or more should be considered for sepsis even in the absence of a SOFA score of 2 or more.
Corresponding author, Yonathan Freund (pictured), told ICU Management & Practice in an email that these findings were beyond the researchers' expectations. They hoped that they would be able to validate qSOFA by reporting a difference of at least 10% of mortality; they actually reported a 21% difference between the two groups.
Freund commented that with qSOFA being highly predictive of severe outcome, infected patients with at least 2 points of qSOFA might be screened very early in the ED. Patients at higher risk of sepsis could benefit from an appropriate care bundle that will be initiated at an early stage, and to a more accurately selected group of patients.
Published on : Tue, 17 Jan 2017
Intended for the exchange of laryngeal mask airways and endotracheal tubes using a fibreoptic bronchoscope, bronchoscopic port, wire guide, and exchange catheter. Features and benefits The set may be used for emergency, urgent, and elective...
Intended for assisted fibreoptic intubation and for uncomplicated, atraumatic endotracheal tube exchange. Features and benefits The catheter’s inner diameter (ID), lumen, and distal sideports are designed to enhance airflow. The large...
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
Features SV 300 is a state-of-the-art ventilator that’s simple to configure, easy to operate and versatile in use. It equips with extensive ventilation modes that can treats pediatric and adult patients with all acuity levels at ICUs and Intermediate...
Extracorporeal organ support for enhanced patient well-being Dedicated technology combines both heart and lung support in one single platform – a platform that is universally usable, individual, safe, and compatible with applications of our parent...